Capstone Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $2.91M | Sell |
22,598
-2,830
| -11% | -$365K | 0.08% | 291 |
|
|
2017
Q1 | $2.78M | Buy |
25,428
+230
| +0.9% | +$25.2K | 0.08% | 305 |
|
|
2016
Q4 | $1.86M | Buy |
25,198
+907
| +4% | +$66.8K | 0.05% | 407 |
|
|
2016
Q3 | $2.12M | Buy |
24,291
+460
| +2% | +$40.1K | 0.06% | 375 |
|
|
2016
Q2 | $2.05M | Buy |
23,831
+830
| +4% | +$71.4K | 0.06% | 376 |
|
|
2016
Q1 | $1.83M | Buy |
23,001
+930
| +4% | +$73.9K | 0.05% | 421 |
|
|
2015
Q4 | $2.78M | Buy |
22,071
+2,231
| +11% | +$281K | 0.08% | 299 |
|
|
2015
Q3 | $2.07M | Buy |
19,840
+1,175
| +6% | +$122K | 0.06% | 356 |
|
|
2015
Q2 | $2.31M | Buy |
18,665
+2,498
| +15% | +$308K | 0.07% | 346 |
|
|
2015
Q1 | $1.91M | Buy |
16,167
+390
| +2% | +$46K | 0.05% | 404 |
|
|
2014
Q4 | $1.87M | Sell |
15,777
-7,210
| -31% | -$856K | 0.05% | 396 |
|
|
2014
Q3 | $2.58M | Buy |
22,987
+190
| +0.8% | +$21.3K | 0.09% | 273 |
|
|
2014
Q2 | $2.16M | Sell |
22,797
-3,021
| -12% | -$286K | 0.07% | 321 |
|
|
2014
Q1 | $1.83M | Sell |
25,818
-2,550
| -9% | -$180K | 0.06% | 390 |
|
|
2013
Q4 | $2.11M | Sell |
28,368
-12,838
| -31% | -$954K | 0.06% | 364 |
|
|
2013
Q3 | $3.12M | Buy |
41,206
+6,890
| +20% | +$522K | 0.08% | 300 |
|
|
2013
Q2 | $2.75M | Buy |
+34,316
| New | +$2.75M | 0.07% | 311 |
|